Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Critical Reviews in Oncogenesis|February 3, 2023
Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic ApplicationsNira Ben-Jonathan, Dana C Borcherding, Eric R HugoEndocrinology|July 12, 2008
Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathwaysChristopher R LaPensee, Eric R Hugo, Nira Ben-JonathanMolecular and Cellular Endocrinology|May 13, 2009
Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndromeNira Ben-Jonathan, Eric R Hugo, Terry D BrandebourgCancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1Nira Ben-Jonathan, Dana C Borcherding, Sejal Fox, et al.Discovery Medicine|April 29, 2011
Prolactin in breast and prostate cancer: molecular and genetic perspectivesEric M Jacobson, Eric R Hugo, Dana C Borcherding, et al.Plos One|January 30, 2014
Placental lactogen is expressed but is not translated into protein in breast cancerTraci R Tuttle, Eric R Hugo, Wilson S Tong, et al.Trends in Endocrinology and Metabolism: TEM|March 7, 2006
Focus on prolactin as a metabolic hormoneNira Ben-Jonathan, Eric R Hugo, Terry D Brandebourg, et al.Trends in Endocrinology and Metabolism: TEM|September 18, 2010
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptorEric M Jacobson, Eric R Hugo, Traci R Tuttle, et al.The Journal of Clinical Endocrinology and Metabolism|July 24, 2008
Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytesEric R Hugo, Dana C Borcherding, Keith S Gersin, et al.Cancer Biology & Therapy|April 12, 2007
LS14 cells: a model for chemoresistance in liposarcomaElizabeth W LaPensee, Shamantha P Reddy, Eric R Hugo, et al.Pageof 2